| A cannabis preparation for neuropathic pain. | Oral cannabidivarin (CBDV) solution for treatment of HIV-associated neuropathic pain – a randomized, double-blind, placebo-controlled phase II study. - Cannabidivarin (CBDV) for neuropathic pain in HIV | EUCTR2014-005344-17-DE |
| Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) | Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) | NCT03202303 |
| Efficacy And Withdrawal Symptoms in Transition Between Cannabidivarin (CBDV) and Cannabidiol (CBD) in Children with Rett Syndrome and Refractory Epilepsy | Efficacy And Withdrawal Symptoms in Transition Between CBDV to CBD in Children with Rett Syndrome and Refractory Epilepsy | ACTRN12624000948594 |